These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 5066136)

  • 1. Shock-induced aggression: effects of 6-hydroxydopamine and other pharmacological agents.
    Thoa NB; Eichelman B; Ng LK
    Brain Res; 1972 Aug; 43(2):467-75. PubMed ID: 5066136
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 3. Apomorphine induced biting and fighting behaviour in reserpinized rats and an approach to the mechanism of action.
    Patni SK; Dandiya PC
    Life Sci; 1974 Feb; 14(4):737-45. PubMed ID: 4856759
    [No Abstract]   [Full Text] [Related]  

  • 4. Pituitary follicle-stimulating hormone activity in rats treated with apomorphine, pimozide and drugs that modify catecholamine levels.
    Choudhury SA; Sharpe RM; Brown PS
    Neuroendocrinology; 1973; 12(4):272-83. PubMed ID: 4731030
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of changes in brain monoamine metabolism on behaviour of herpes simplex-infected mice.
    Lycke E; Roos BE
    J Neurol Sci; 1974 Jul; 22(3):277-89. PubMed ID: 4151982
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of peripherally administered 6-hydroxydopamine on rat brain monoamine turnover.
    Clark WG; Corrodi H; Masuoka DT
    Eur J Pharmacol; 1971 Jun; 15(1):41-4. PubMed ID: 5161339
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective lesions of central catecholamine pathways: application in functional studies.
    Ungerstedt U
    Neurosci Res (N Y); 1973; 5(0):73-96. PubMed ID: 4600813
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats.
    Herz A; Bläsig J; Papeschi R
    Psychopharmacologia; 1974; 39(2):121-43. PubMed ID: 4476079
    [No Abstract]   [Full Text] [Related]  

  • 9. Brain amine levels and competitive behavior between rats in a straight runway.
    Masur J; Czeresnia S; Skitnevsky H; Carlini EA
    Pharmacol Biochem Behav; 1974; 2(1):55-62. PubMed ID: 4275179
    [No Abstract]   [Full Text] [Related]  

  • 10. [Brain amines and apomorphine-induced intraspecific aggressive behavior in the rat (author's transl)].
    Senault B
    Psychopharmacologia; 1974 Jan; 34(2):143-54. PubMed ID: 4274176
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of dopaminergic stimulation or blockade on morphine-withdrawal aggression.
    Puri S; Lal H
    Psychopharmacologia; 1973; 32(2):113-20. PubMed ID: 4796281
    [No Abstract]   [Full Text] [Related]  

  • 12. [Uptake and storage of catecholamines by adrenergic fibers of the central and peripheral nervous system. II. Preferential retention of noradrenaline].
    L'Hermite P
    Arch Anat Microsc Morphol Exp; 1969; 58(3):257-82. PubMed ID: 4316936
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective reserpine-resistant accumulation of catecholamines in central dopamine neurones after DOPA administration.
    Lidbrink P; Jonsson G; Fuxe K
    Brain Res; 1974 Mar; 67(3):439-56. PubMed ID: 4470434
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of brain catecholamines with cortical acetylcholine outflow, behaviour and electrocorticogram.
    Beani L; Bianchi C; Castellucci A
    Eur J Pharmacol; 1974 Apr; 26(1):63-72. PubMed ID: 4831985
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical and behavioural effects of tyrosine hydroxylase inhibition.
    Hanson LC
    Psychopharmacologia; 1967; 11(1):8-17. PubMed ID: 5596865
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of alpha-methyltyrosine-induced behavioural depression with dihydroxyphenylalanine and amphetamine.
    Moore KE; Rech RH
    J Pharm Pharmacol; 1967 Jun; 19(6):405-7. PubMed ID: 4382374
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro uptake of dopamine in serotoninergic nerve terminals: a fluorescence histochemical study on vibratome sections of the rat cerebral cortex.
    Berger B
    Adv Biochem Psychopharmacol; 1978; 19():405-8. PubMed ID: 358786
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological modifications of the 6-hydroxy-dopa induced degeneration of central noradrenaline neurons.
    Jonsson G; Sachs C
    Biochem Pharmacol; 1973 Jul; 22(14):1709-16. PubMed ID: 4715992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.